U.S. policy on some technologies like bioweapons was anticipatory, motivated by recognizing that bioweapons technology would get cheaper and more accessible, making it strategically preferable for the U.S. to prevent proliferation through the Bioweapons Convention rather than allowing universal access to mass death capabilities, which is why the U.S. unilaterally dropped bioweapons and encouraged other nations to do the same.